Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redox-Neutral Assembly of Selenobenzothiazine 1-Oxides via Rh(III)-Catalyzed Cascade [4 + 2] Annulation/Selenylation.

Organic letters·2026
Same author

Generation of Carbon and Phosphine Stereocenters via Cobaltaphotoredox-Catalyzed Enantioselective C-H Annulation.

Organic letters·2026
Same author

Lenvatinib induces ferroptosis-related changes in osteosarcoma cells involving the p-STAT3/p53/xCT axis.

Frontiers in oncology·2026
Same author

Calcium(II)-Catalyzed Three-Component Alkoxyselenation of Allenes with Selenium-Nitrogen Exchange (SeNEx) Reagents.

Organic letters·2026
Same author

Highly potent C-type nanoantibodies neutralize Nipah and Hendra viruses by cavity filling on fusion glycoprotein.

Nature communications·2026
Same author

A unified cobalt-electrocatalytic platform for enantio- and stereo-selective C-H and C-F functionalization of <i>gem</i>-difluoromethylene allenes.

Chemical science·2026

Related Experiment Video

Updated: Aug 19, 2025

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.6K

Ferroptosis in osteosarcoma: A promising future.

Xiang Liu1,2, Shaowen Du1,2, Shengdong Wang1,2

  • 1Department of Orthopedics, Second Hospital of Lanzhou University, Lanzhou, China.

Frontiers in Oncology
|December 2, 2022
PubMed
Summary

Osteosarcoma (OS) treatment is challenging due to recurrence and chemotherapy resistance. Ferroptosis, a cell death form, shows promise in overcoming resistance and improving outcomes for OS patients.

Keywords:
chemotherapy resistanceferroptosismolecular mechanismsosteosarcomatumor treatment

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.7K
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.1K

Related Experiment Videos

Last Updated: Aug 19, 2025

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

9.6K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.7K
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.1K

Area of Science:

  • Oncology
  • Cell Death Mechanisms
  • Biochemistry

Background:

  • Osteosarcoma (OS) incidence is rising, with poor prognosis in advanced cases due to recurrence and chemotherapy resistance.
  • Programmed cell death (PCD) offers potential therapeutic strategies for OS.
  • Ferroptosis, a novel iron-dependent cell death pathway, is implicated in OS progression and treatment response.

Purpose of the Study:

  • To review the regulatory mechanisms of ferroptosis.
  • To summarize the research progress of ferroptosis in osteosarcoma.
  • To explore the therapeutic potential of ferroptosis for OS.

Main Methods:

  • Literature review of ferroptosis mechanisms.
  • Analysis of current research on ferroptosis in osteosarcoma.
  • Synthesis of findings related to ferroptosis and OS treatment.

Main Results:

  • Ferroptosis is regulated by iron metabolism, lipid peroxidation, and specific signaling pathways.
  • Ferroptosis induction can overcome chemotherapy resistance in osteosarcoma models.
  • Targeting ferroptosis presents a promising strategy for managing advanced OS.

Conclusions:

  • Ferroptosis is a critical factor in osteosarcoma development and treatment.
  • Understanding ferroptosis regulation is key to developing novel therapeutic approaches for OS.
  • Ferroptosis-based therapies hold significant potential for improving clinical outcomes in osteosarcoma patients.